Aster DM Healthcare Intrinsic Value
ASTERDM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹186.31 | ₹149.05 - ₹223.57 | -70.0% | EPS: ₹8.52, Sector P/E: 12x |
| Book Value Method | asset | ₹124.21 | ₹111.79 - ₹136.63 | -80.0% | Book Value/Share: ₹73.02, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹186.31 | ₹167.68 - ₹204.94 | -70.0% | Revenue/Share: ₹98.08, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹248.42 | ₹223.58 - ₹273.26 | -60.0% | EBITDA: ₹1056.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹248.42 | ₹198.74 - ₹298.10 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹186.31 | ₹167.68 - ₹204.94 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹186.31 | ₹167.68 - ₹204.94 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹310.52 | ₹279.47 - ₹341.57 | -50.0% | ROE: 13.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹186.31 | ₹167.68 - ₹204.94 | -70.0% | EPS: ₹8.52, BVPS: ₹73.02 |
Want to compare with current market value? Check ASTERDM share price latest .
Valuation Comparison Chart
ASTERDM Intrinsic Value Analysis
What is the intrinsic value of ASTERDM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Aster DM Healthcare (ASTERDM) is ₹186.31 (median value). With the current market price of ₹621.05, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹124.21 to ₹310.52, indicating ₹124.21 - ₹310.52.
Is ASTERDM undervalued or overvalued?
Based on our multi-method analysis, Aster DM Healthcare (ASTERDM) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.92 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.81 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 13.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.74x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Aster DM Healthcare
Additional stock information and data for ASTERDM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹425 Cr | ₹425 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹158 Cr | ₹-281 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹1,834 Cr | ₹1,359 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1,314 Cr | ₹1,033 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹1,569 Cr | ₹1,403 Cr | Positive Free Cash Flow | 8/10 |